 |
Journal articles
Diffuse large B-cell lymphoma response rituximab-PMitCEBO regimen is not predicted by FcγRIIa158 polymorphism
Cristina Bagacean
1, 2, 3, 4
Naelle Lombion
5
Adrian Tempescul
3, 5, 1
Jean-Christophe Ianotto
5
Christian Berthou
3, 5, 1
Mihnea Zdrenghea
2, 4
Victor Cristea
2
Cristina Bagacean 1, 2, 3, 4
Author
Naelle Lombion 5
Author
Adrian Tempescul 3, 5, 1
Author
Jean-Christophe Ianotto 5
Author
1
LabEX IGO Immunothérapie Grand Ouest (France)
3
EA2216 - Immunologie et Pathologie (CHU Morvan, 5 Rue Foch, BP 824, 29609 Brest - France)
- UBO - Université de Brest : EA2216 (Université de Bretagne Occidentale - 3 Rue des Archives 29238, Brest - France)
- IFR148 (France)
5
Department of Clinical Hematology, Institute of Cancerology and Hematology (Avenue Foch;29609;Brest - France)
- CHU Morvan (France)
Document type :
Journal articles
Domain :
Complete list of metadata
https://hal.univ-brest.fr/hal-01260185
Contributor : Geneviève Michel Connect in order to contact the contributor
Submitted on : Thursday, January 21, 2016 - 4:11:10 PM
Last modification on : Monday, October 11, 2021 - 2:23:09 PM
Contributor : Geneviève Michel Connect in order to contact the contributor
Submitted on : Thursday, January 21, 2016 - 4:11:10 PM
Last modification on : Monday, October 11, 2021 - 2:23:09 PM
Identifiers
- HAL Id : hal-01260185, version 1
Collections
Citation
Cristina Bagacean, Naelle Lombion, Adrian Tempescul, Jean-Christophe Ianotto, Christian Berthou, et al.. Diffuse large B-cell lymphoma response rituximab-PMitCEBO regimen is not predicted by FcγRIIa158 polymorphism. Human & Veterinary Medecine Bioflux, 2015, 7 (4), pp.298-301. ⟨hal-01260185⟩
Metrics
Record views